Introduction
Without heterogeneity, or variation, there would be no potential for gaining scientific information. Yet, unappreciated heterogeneity can degrade or distort scientific interpretations.Therefore, though heterogeneity may play a negative role in some situations, it is our lifeblood in others. This report discusses issues, techniques, and examples related to assessing, accommodating, interpreting, and controlling the effects of heterogeneity. Though no abstract definition ofheterogeneity is satisfactory for all settings, we shall propose operational definitions that are relevant to specific scientific and practical questions. We do not go into great detail on any specific issue or example, rather we provide an overview and key into a wide literature.
Heterogeneity can be defined in many ways with the most inclusive being variation in general. More results and to put outcomes on a common basis. This adjustment can reduce variability and bias.
The problem ofdefining and identifying sensitive individuals provides another instructive example. As Bailar and Louis (5) discuss for lung responsiveness to challenge, smokers as a group may be considered sensitive relative to nonmokers, yet some smokers (even in the same smoking rate category) are more sensitive than others. This example identifies the question ofscoping the assessment of heterogeneity. One needs to group study units that can be considered homogeneous (follow a baseline model). This decision is made using a combination of scientific and practical considerations. A third class ofexamples, called measurement error models, shows the importance of identifying and accounting for heterogeneity. Consider the effect ofdiastolic blood pressure on risk of stroke. Blood pressure measurements are made with error (6, 7) , and it is well known that estimated regression slopes are attenuated relative to the relation between true blood pressure and risk ofstroke. Ofcourse, the reported regression slope is correct for the question ofhow stroke risk relates to measured blood pressure. But this slope does underestimate the true influence of blood pressure on stroke. MacMahon et al. (8) show, for example, that the reported slope should be increased by approximately 60% to estimate the underlying relation. This increase has profound policy and health implications.
Identifying this attenuation of slope is important when combining evidence over a variety ofstudies through a meta analysis or overview (9) . If each study uses a different measurement system (for example, taking the average ofa different number of blood pressure readings), reported slopes will need adjustment before combining. Failure to do so can result in observed heterogeneity of slopes in excess of that predicted by sampling variability (the baseline model). In this case, the unexplained variation can be explained and accommodated by an error-invariables model.
One more class ofexamples serve to introduce another feature of unappreciated heterogeneity. Vaupel and Yashin (10) and Yashin (11) discuss "heterogeneity's ruses," where the shape of the hazard for death in a population is different from that for any individual. For example, each individual may have a constant hazard (exponential distribution), but the population curve will show a decreasing hazard. Relatively speaking, the frail die out early, leaving the hardy (low hazard) to live. Again, at the population level, the decreasing hazard is appropriate, but ifone wishes to study aging or policy impacts, an understanding of the ruses and an attempt using data and theory to uncover them is vital. These ruses are just another example of Simpson's paradox.
Thepolicy issue in survival models iseasily seen instudiesofthe effects ofsmokingcessationontheriskoflungcancer. A multistage model predicts thatthe excess riskcontinues to increaseevenafter an individual stops smoking (though the increase is less than for an individual who continues to smoke), whereas many data sets show that the excess decreases. The decrease may be true, and surely is for the population, but each individual's excess risk may indeed increase, but heterogeneously.
The facts discussed so far, suggest several definitions of heterogeneity, including general variability, variability in excess of a baseline model, variance components, measurement error, variation in latent parameters. To these definitions we can add heterogeneity induced by variation in data analytic approaches. In the end, heterogeneity is a vague concept and is best appreciated through a series of examples.
Two-Stage Models Basic
The two-stage model provides a convenient way to represent variation in excess of a baseline model. In this model we have stage II: a parameter (vector) is sampled from a distribution; and stage I: data are generated from a sampling distribution, conditional on the parameter. This two-stage sampling process can be repeated for each experimenal unit (e.g., clinics, petri dishes, small geographic areas), and underlies Bayes and empirical Bayes analysis. For concreteness, consider a stage II governed by a prior distribution (G) that is Gaussian and that stage I is Gaussian with a known variance (12, 13) . Let (yYk-Y)2= 10, and we know (assume) that a2 = 6, then a natural estimate for r2 is 4 . If, however, we assume 2 = 9, then -r = 1. In practice, we need either direct information on sampling variation (through replication within units) or reliable assumptions (e. g., use ofarcsine transformed binomial data) to identify T2.
For another example ofa two-stage model, consider the case where the sampling distribution is Poisson (14, 15 V,E is n times VF.
The design effect and generalizations thereof can be used to determine how many repeat measurements on a unit (n) and how many units (K) are needed to produce a desired accuracy. Setting n = 1 minimizes the number of observations, but generally repeat observations on a unit are more relevant or less expensive than adding units, so an n > I usually produces the opimal solution under resource constraints.
The decision to use fixed or random effects depends on inferential goals, and differences in goals underlie the current controversy over when to use meta analysis (16) . The random effects approach produces considerably larger standard errors on an estimated treatment effect than does the fixed effects analyses. Peto and colleagues argue in favor of inferences limited to the meta-analyzed studies and used fixed effects (17) . Others desire a broadened inference to the population of similar studies, and this promotes random effects (18) . The narrow inference has a well-defined reference population but does not easily genealize.
The broad inference is possibly more relevant, but the target population is somewhat vague.
Irrespective ofthese scoping issues, the stage II variance component can be ofindependent interest. Consider the metaanalysis ofthe effect ofcoaching on scholastic aptitude test (SAT) scores conducted by Laird and DerSimonian (19) . Table 1 shows that estimated effects are greater for uncontrolled than for controlled studies (likely because much of the coaching effect is really regression to the mean), reports the stamdard error ofthe estimate (the SE depends both on the number of studies and the sample size for each study), and shows that the stage II variability is greater for uncontrolled studies. We can see that unexplained variation is greater for the uncontrolled studies (it is likely that dty are perforned under a wide variety ofconditions) and under the Gaussian assumption can get an idea ofthe variation in true coaching effect. True coaching effect for uncontrolled studies can be expected to vary according to a N(41, 252) distribution, while for matched/randomized studies it follows something close to a N (10, 32) . This information is ofpolicy interest. For example, it is virtually impossible for there to be a negative coaching effect Tnbke 1. The effect of coachn on SAT scores (19 14 3 There were nine studies.
in the randomized approach applied to populations similar to those used in the current studies.
Tests for heterogeneity in a Gaussian framework ask if T2 = 0. In general, these tests are less informative than reporting an estimate, where one can determine if the excess variation is a threat to interpretation or generalization. Consider, for example, the meta analysis conducted by Beaumont and Breslow (20) on the cancer risk from vinyl chloride. Table 2 (21) . In each of 3420 sampling sites, 5 samples were taken and the number of contaminated samples recorded. Table 3 gives the data and expected frequencies (rounded) under the binomial distribution, computed with the estimated contmination probability of0.025. For this event probability, the binomial assumption predicts far too few occurences of 2 to 5, and a two-stage variance components model can capture the excess variation among geopraphic areas. The sample variance of the observed contaminations is 0.1885, which is greater than the 0.1219 predicted from the binomial [0.1219= 5(0.025)(0.975)J, suggesting overdispersion.
The beta distribution is a common model for stage II, and we parameterize it by the mean, ju, and intraclass correlation (M + 1)'. Specifically, with 0 the binomial parameter:
From the Von Mises data, we obtain i =0.025, M = 6.2. The 62 shows high apriori variation, whereas an M -+ oo would indicate no prior variation. We can go further with this example and free ourselves from assuming a specific parametric shape for the prior by using a nonparametric estimate. Laird (22) This improvement in estimates carries over to improved confidence intervals in that they attain the nominal coverage but are of shorter length than the classical intervals (13, 34) . This empirical Bayes advantage holds even when the intervals are broadened to account for uncertainty in estimating the prior distribution. With the development ofcalibrated confidence intervals, the empirical Bayes approach produces inferences ideally suited to risk assessment investigations when data from related sources are available. accuracies, then failure to account for these differences will produce apparently different slopes. Any meta analysis ofexperimental results will require adjustment to a common basis. (b) Pbssibly more importantly, even though the unadjusted slope is appropriate for relating measured dose to response, it is inappropriate when making policy recommendations. For example, many studies report on the positive relation between blood pressure and heart attack risk. Since blood pressure generally is measured with considerable variation, the effectiveness ofblood pressure control is underestimated. Since policies are aimed at reducing true blood pressure, the adjusted slope is relevant.
Consequences of Heterogeneity
Many authors have discussed the consequences of errors in variables and methods for reducing the effects through design and analyses (6,7,37-4(1) . Design considerations include averaging repeated measures to reduce heterogeneity. Analyses that explicitly or implicitly de-attenuate regression slopes are effective in performing the necessary adjustments. In studies relating a risk factor to a response in the presence ofa confounder, Kupper (6) shows that unreliability in measurement of the confounder can be more damaging than unreliability in the risk factor, sometimes producing a sign change between the estimated slope and the slope appropriate for true confounder-adjusted risk. Extreme care is needed in defining research questions, designing, and analyzing studies.
The effects of unaccommodated heterogeneity can be more dramatic than slope attenuation. Consider the linear model Y = a + bx + error where x is the true regressor. Let the observed regressor (X) conditional on the true regressor be distributed as a log-normal variable with mean x. Then, the regression using the observed regressor is: y = a + bXP+ error, where p < 1, so a linear relation is converted to nonlinear. Bailar et al. (41) suggest that this type of phenomenon (operating as variation in true slope from rodent to rodent) may produce the ap parent lack of conservatism for linear extrapolation of doseresponse relations. The dose-response curve for vinyl chloride is a classic example.
When we start with a nonlinear model, such as a logistic regression or a multistage model for carcinogenicity, heterogeneity due to noisy regressors or due to variations in true slopes from unit to unit (the compound model) change the shape of the relation. Techniques are available for estimating and adjusting (39,41) but more development of numerical methods is required.
Survival Analysis
Survival analysis gives a particularly transparent view of the influence ofheterogeneity (10, 11, (43) (44) (45) (46) (47) . Recall that the hazard, or force of mortality, is defined as:
At(t)dt = pr(death in (t,t+dt) I alive at t).
With S(t) the survival curve:
Assume that each individual in a population has a hazard depending on a parameter 0 that multiplies a baseline hazard (proportional hazards), and that 0 varies from person to person according to a probability distribution G (again, the two-stage model). Then, for the population:
and IzG(t) h(t) * EG(6I T>t), where h is the basline hazard, and H is its integral. It can be shown the EG (0 I T >t) is decreasing in t so that the shape of it (t) is different from that of h(t).
Vaupel and Yashin (10) give several examples ofthis difference in shape. The easiest example has h(t) 1 
Risk Assessment
The decision on using historical controls in the analyses ofthe carcinogen bioassay illuminates several issues related to heterogeneity. Consider a bioassay comparing lifetime tumor rates between an exposed and control group ofrodents, each with 50 rodents. Table 4 presents typical data when all tumors occur in the exposed group. The Fisher's exact one-sidedp-value is approximately (0.5)x, so that if x is less than 5, thep-value will exceed the usual level for statistics significance. Thep-values for X = 0,1,2,3,4,5 are 1.000, 0.500,0.247,0.121, 0.059, and 0.028. However, in many situations pathologists will report that even an X = 3 is biologically significant because in a long series of experiments virtually no tumors ofthe type being considered have been found in the control group. This dissensus between the statistical procedure and scientific opinion can be explained and rectified by a two-stage model where the control rate for the current experiment is considered to be sampled from a prior distribution. In the case we are considering, this prior puts almost all weight on a control rate of 0 and is equivalent to increasing the control sample size. For (49) , and the references thereof explain approaches. Formalized use ofthe historical data will help resolve controversies such as those that surrounded the assay for DMT (dimethylterephthalate), where the data showed 2 %, 16%, and 27 % lifetime incidence of alveolar/broncheolar adenomas and carcinomas in male mice for the control, low-, and high-dose groups (p<0.0001), but previous control groups in the same laboratories had rates of 10%, 13%, and 18% (50) . Refinements are needed to incorporate time-until-tumor and cause-of-death information, and the approach should be included as a formal method offocusing discussion ofbioassay results. As evidenced by Freedman (5S), the carcinogen bioassay generates uncertainty and controversy more broadly.
Hierarchical models incorporating complicated variance component structures have been used to relate data from seemingly unrelated human studies and to formalize interspecies extrapolations ofRisk. DuMouchel and Harris (52) present an analysis of the health effects ofenvironmental emissions, and Laird (53) investigates the thyroid cancer risk of ionizing radiation. Both of these analyses carefully lay out assumptions and study sensitivity of results to changes in assumptions. The formal approach provides explicit documentation ofmethods and helps focus discussion of modifications. These models will always be augmented by expert opinion and political considerations when used as input to risk assessment and control, but they serve an extremely valuable role, going beyond more descriptiveapproaches such as those ofCrouch and Wilson (54).
Scoping
When assessing or accommodating heterogeneity, the analysis frame is extremely important. One needs to decide on the basic unit of analysis (e.g., the individual, the publication, the small geographic area), the baseline model (e.g., logistic dose response, PRisson counts), the form ofheterogeneity (e.g., gamma, Gaussian), and the type of units to be admitted to the analysis. We refer to the types ofunits analyzed as scoping, and it concerns defining the types ofunits that can be expected to be related by the heterogeneity distribution. Too 
Summary
We have seenthat heterogeneity is the foundation of statistical science and that its identification and accommodation is centrally important to the design, conduct, analysis, and interpretation of statistical studies. Key issues include determining baseline models and defining analytic goals. Ifthe goals are primarily to make inferences at the population level, then heterogeneity modeling is quite robust and generally serves to expand the flexibility of population models to represent expectations and variances. If, however, inferences are directed at the unit-specific level, considerable care is needed in specifying baseline models and forms for heterogeneity. Commonly, true replications at the unit level are unavailable, and models will be based on a combination of scientific reasonableness and statistical/mathematical convenience. Usually, the specific forms chosen are not uniquely best for the observed data, and careful interpretation coupled with sensitivity analysis is required.
Effective assessments, accommodations, and interpretations ofheterogeneity require effective team work among statisticians and other scientists tuning the approach to the application. The scientifically challenging and societally important problems in quantitative risk assessment provide fertile ground for developing and applying methods that will increase scientific understanding and improve the public health.
